SURG-DUKE-CEPPA-VAC; A Randomized Phase II Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery
Eugene Ceppa, MD
Primary Investigator
Overview
The purpose of this study is to compare the rate of surgical site infection between traditional wound care and negative pressure wound therapy.
Description
The purpose of this study is to evaluate whether incisional negative pressure wound therapy (NPWT) can help reduce the rate of surgical site infections in patients undergoing either colorectal or hepatopancreatobiliary surgery.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
colorectal surgery,hepatopancreatobiliary surgery
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria
Scheduled for an elective surgery in either open CRS or open HPBS. This includes, but is not limited to: ileocecectomy, right hemicolectomy, extended right hemicolectomy, transverse colectomy, left hemicolectomy, sigmoidectomy, proctectomy, low anterior resection, or abdominoperineal resection gastrectomy, hepatectomy, bile duct reconstruction, duodenectomy, pancreatectomy, pancreaticoduodenectomy, or pancreatic duct reconstruction
Exclusion Criteria
The need for emergency surgery
The need for use of only laparoscopic surgery
Presence of bowel obstruction, strangulation, peritonitis or perforation
The presence of local or systemic infection preoperatively
ASA class >=4
Inability to provide informed consent and authorization
Known allergy or hypersensitivity to silver
Any clinically significant condition that, in the investigator's opinion, would significantly impair the subject's ability to comply with the study
